[go: up one dir, main page]

CN105623937A - Saccharifying method - Google Patents

Saccharifying method Download PDF

Info

Publication number
CN105623937A
CN105623937A CN201610097716.7A CN201610097716A CN105623937A CN 105623937 A CN105623937 A CN 105623937A CN 201610097716 A CN201610097716 A CN 201610097716A CN 105623937 A CN105623937 A CN 105623937A
Authority
CN
China
Prior art keywords
beer
amylopectase
aforementioned
beerwort
amylase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610097716.7A
Other languages
Chinese (zh)
Inventor
尼尔斯·埃尔维格
珀·L·乔尔根森
迈克尔·托马斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Novozymes Inc
Original Assignee
Novo Nordisk AS
Novozymes Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS, Novozymes Biotech Inc filed Critical Novo Nordisk AS
Priority claimed from CN2007801019200A external-priority patent/CN101918525A/en
Publication of CN105623937A publication Critical patent/CN105623937A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12CBEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
    • C12C7/00Preparation of wort
    • C12C7/04Preparation or treatment of the mash
    • C12C7/047Preparation or treatment of the mash part of the mash being unmalted cereal mash
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2451Glucanases acting on alpha-1,6-glucosidic bonds
    • C12N9/2457Pullulanase (3.2.1.41)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01041Pullulanase (3.2.1.41)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

本发明涉及糖化方法,具体地提供用于产生啤酒用麦芽汁的方法,其中包括从谷物形成醪,和将所述醪与支链淀粉酶接触。The present invention relates to a mashing process and in particular provides a process for producing beer wort comprising forming mash from grain and contacting said mash with pullulanase.

Description

Method for saccharifying
The present patent application is based on the applying date and is December in 2007 12, and application number is the divisional application that 200780101920.0 (international application no is PCT/US2007/087209), name are called the application for a patent for invention of " method for saccharifying ".
Quoting sequence table
The present invention comprises the sequence table of computer-reader form. By reference computer-reader form is expressly incorporated herein.
Invention field
The present invention relates to for producing medicated beer beerwort and for producing the method for saccharifying of the improvement of medicated beer.
Background of invention
In modern method for saccharifying, when the diastatic Fructus Hordei Germinatus amount in enzyme is relatively low or allows to use all auxiliary corn (adjunctgrist), often enzyme agent as a supplement is added. Also in the saccharifying carrying out the fully Fructus Hordei Germinatus of modification with high-load enzyme, enzyme is used, to increase the amount of extraction recovery and fermentable sugars. Therefore known application debranching enzyme, for instance, isoamylase or amylopectase, to increase the yield of fermentable sugars. Application debranching enzyme in the method for low-heat beer can be produced being used for. This method is the theme of (MBAATechnicalQuarterly, 1977,14:105), U.S. Patent No. 4,528,198,4,666,718 and 4,318,927 and GB2056484 and the GB2069527 such as Willow.
Summary of the invention
The present inventor it has now surprisingly been found that by use certain amylopectase, it is possible to use lesser amount of pheron and realize saccharifying.
Therefore, in first aspect, the method that the present invention is provided to produce medicated beer beerwort, wine with dregs is formed including by corn, and described wine with dregs is contacted with amylopectase (E.C.3.2.1.41), wherein said amylopectase has aminoacid, aminoacid sequence at least 50% shown in described aminoacid sequence a) and SEQIDNO:4 is identical, or b) by under low stringent condition with the nucleic acid sequence encoding of following hybridization: i) encode the complementary strand of the nucleotide sequence of aminoacid sequence shown in SEQIDNO:4, or ii) subsequence of at least 100 nucleotide of (i).
In second aspect, the present invention provides according to the beerwort produced by the method for first aspect.
In the third aspect, beerwort that is that the present invention provides the concentration produced by the method for first aspect and/or that dry.
In fourth aspect, the present invention provides the medicated beer produced by the beerwort of second and third aspect.
In the 5th, the present invention provides the compositions suitable in the method for first aspect, described compositions includes amylopectase (E.C.3.2.1.41), glucoamylase and optional ��-amylase, wherein amylopectase has aminoacid sequence, aminoacid sequence at least 50% shown in described aminoacid sequence a) and SEQIDNO:4 is identical, or b) by under low stringent condition with the nucleic acid sequence encoding of following hybridization: i) encode the complementary strand of the nucleotide sequence of aminoacid sequence shown in SEQIDNO:4, or ii) subsequence of at least 100 nucleotide of (i).
In particular it relates to every as follows:
1. the method being used for producing medicated beer beerwort (Brewer ' swort), forms wine with dregs including from corn, contacts with amylopectase with by described wine with dregs, and wherein said amylopectase has following aminoacid sequence:
A) identical with aminoacid sequence at least 86% shown in SEQIDNO:4; Or
B) by nucleic acid sequence encoding, described nucleotide sequence under low stringent condition with following hybridization:
I) complementary strand of the nucleotide sequence of aminoacid sequence shown in coding SEQIDNO:4; Or
Ii) subsequence of at least 100 nucleotide of (i).
2. the method according to item 1, wherein said amylopectase is derived from addicted to acid Pullulan bacillus cereus (Bacillusacidopullulyticus).
3. the method according to item 1 or 2, it farther includes to contact described wine with dregs with glucoamylase and/or ��-amylase.
4. the method any one of aforementioned item, wherein glucoamylase and/or ��-amylase are derived from aspergillus niger (Aspergillusniger) or Ai Mosen ankle joint bacterium (Talaromycesemersonii).
5. the method any one of aforementioned item, it farther includes to contact described wine with dregs with the enzyme selected from lower group: cellulase, isoamylase, xylanase and protease.
6. the method any one of aforementioned item, wherein said corn includes the grain germinateing and/or not germinateing.
7. the method any one of aforementioned item, the grain wherein not germinateed and/or the grain of germination are selected from following: Fructus Hordei Vulgaris, Semen Tritici aestivi, rye (Secale cereale L.), Sorghum vulgare Pers., broomcorn millet, Semen Maydis and rice.
8. the method any one of aforementioned item, the grain wherein germinateed includes the germination grain being selected from the Fructus Hordei Vulgaris, Semen Tritici aestivi, rye (Secale cereale L.), Sorghum vulgare Pers., broomcorn millet, Semen Maydis and the rice that germinate.
9. the method any one of aforementioned item, wherein said beerwort is concentration and/or dries.
10. the method any one of aforementioned item, it also includes fermenting wort to obtain alcoholic beverage.
11. the method according to item 10, wherein said alcoholic beverage is medicated beer.
12. the method according to item 11, wherein said medicated beer is to like youngster's medicated beer, strong love youngster's medicated beer, Bitter, stou, alms bowl that dark beer, old storage medicated beer, export-oriented medicated beer, malt liquor, barley broo, low malt medicated beer, high alcohol beer, low alcohol beer, low-heat beer or light beer thoroughly.
13. the beerwort produced by the method any one of aforementioned item.
14. the concentration any one of aforementioned item and/or dry beerwort.
15. the medicated beer produced by the beerwort any one of aforementioned item.
16. the compositions suitable in the method any one of aforementioned item, described compositions includes amylopectase, glucoamylase and optional ��-amylase, and wherein said amylopectase has following aminoacid sequence, described aminoacid sequence
A) identical with aminoacid sequence at least 50% shown in SEQIDNO:4; Or
B) by under low stringent condition with the nucleic acid sequence encoding of following hybridization:
I) coding SEQIDNO:4 shown in aminoacid sequence nucleotide sequence complementary strand or
Ii) subsequence of at least 100 nucleotide of (i).
17. the compositions according to item 16, wherein glucoamylase and/or ��-amylase are derived from aspergillus niger or Ai Mosen ankle joint bacterium.
Detailed Description Of The Invention
Brewing method is it is well known in the art that and generally include malting (malting), saccharifying (mashing) and the step fermented. Saccharifying is that autoclase barley malt becomes to ferment with the Starch Conversion of solid adjuvant material and not fermentable sugar in the future, thus the method producing there is the beerwort of desirable composition. Traditional saccharifying includes broken barley malt and adjuvant and water at design temperature with to set volume mixture, so that the biochemical change started in malting technique proceeds. Method for saccharifying carries out one period in various temperature, to activate responsible protein degradation matter and the endogenous enzymes of sugar. Up to now, the most important change brought in saccharifying is that starch molecule is changed into fermentable sugars. The main enzyme being responsible for Starch Conversion in traditional method for saccharifying is ��-and beta amylase. ��-amylase by resolving into the shorter chain and the soluble and solvable starch that quickly reduces that much can be subject to beta amylase attack by starch molecule. The disaccharide produced is maltose. Except the maltose formed in saccharifying, also produce short branched glucose oligomer. Short branched glucose oligomer is not fermentable sugar, it is possible to makes finished beer taste better, and increases heat.
After saccharifying, when all starch all decompose, it is necessary to separate liquid extract (beerwort) from solid (distiller grains). The separation of beerwort and filter critically important, because solid comprises substantial amounts of protein, (poorlymodified) starch of basic unmodified, fatty material, silicate and polyphenol (tannin). After distiller grains separation of wort, it is possible to ferment distiller grains to produce medicated beer with brewer's yeast.
Details about conventional brewing method can at ResearchandTeachingInstituteofBrewing, " TechnologyBrewingandMalting " of the WolfgangKunze of Berlin (VLB), second edition revised edition in 1999, finds in ISBN3-921690-39-0.
The short branched glucose oligomer formed in saccharifying can be hydrolyzed further by adding exogenous enzyme (enzyme added except Fructus Hordei Germinatus). Debranching enzyme such as amylopectase (pullulanase) and isoamylase (isoamylase) are hydrolyzed the side chain ��-1-6 glycosidic bond in these oligomers, thus discharging glucose or maltose and straight chain oligomer, it is subject to endogenous enzymes (being derived from Fructus Hordei Germinatus) and/or exogenous enzyme, such as, the effect of ��-amylase, beta amylase and glucoamylase.
The present invention provides and is suitable to produce the new method of the not beerwort that fermentable sugars content is low. The method uses regioselective Pullulanase activity.
Definition
In content of this disclosure, employ multiple terms that those of ordinary skill in the art are generally understood that. But, several terms employ specific implication, and implication is limited as follows.
As it is used herein, term " corn (grist) " is interpreted as the material containing starch or sugar, it is the basis of Beer Production, for instance, barley malt and adjuvant. Generally, corn does not comprise the water of any interpolation.
Term " Fructus Hordei Germinatus " is interpreted as cereal grains (maltedcerealgrain), particularly Fructus Hordei Vulgaris of any germination.
It is interpreted as in corn by term " adjuvant " not being the part of barley malt. Adjuvant can include the vegetable material of any rich in starch, and e.g., the corn not germinateed, such as Fructus Hordei Vulgaris, rice, Semen Maydis, Semen Tritici aestivi, rye (Secale cereale L.), Sorghum vulgare Pers. and the sugar and/or the syrup that are prone to fermentation.
Being interpreted as wrapping amyloid slurry by term " wine with dregs (mash) ", this slurry comprises the corn being dipped in water.
Term " beerwort " is interpreted as in saccharifying and extracts the unfermentable liquid efflunent (liquorrun-off) after corn.
Term " distiller grains " is interpreted as (drained) solid drained remaining after extracting corn and separation of wort.
Term " medicated beer " is understood herein to the beerwort after fermentation, i.e. from barley malt, the pick-me-up (alcoholicbeverage) that optional adjuvant and Flos lupuli (Flos Humuli Lupuli) are brewageed.
Term " homologous sequence " is used for being characterized as below sequence, it has and known array at least 70%, preferably at least 75%, or at least 80%, or at least 85%, or 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or even at least 100% identical aminoacid sequence. the relevant portion of the aminoacid sequence determined for homology is mature polypeptide, i.e. without signal peptide. term " homologous sequence " is also used for being characterized in the DNA sequence of low stringency, middle stringency, medium/high stringency, high stringency, or even very high stringency and known array hybridization. for determining low, in or the suitable experiment condition of intermolecular hybrid of high stringency nucleotide probe and homologous dna or RNA sequence include: by comprise DNA fragmentation or RNA filter membrane preimpregnation with in 5xSSC (sodium chloride/sodium citrate, Sambrook etc., 1989) hybridization 10 minutes in, and at 5xSSC, 5xDenhardt solution (Sambrook etc., 1989), by filter membrane prehybridization (Sambrook etc. in the solution of 0.5%SDS and 100 microgram/ml degeneration supersound process salmon sperm DNA, 1989), then random (Feinberg and the Vogelstein caused that concentration is 10ng/ml is being comprised, 1983, Anal.Biochem.132:6-13), hybridize 12 hours at about 45 DEG C with in the same solution of (specific activity > 1x109cpm/ microgram) probe of 32P-dCTP labelling. then by filter membrane at 2xSSC, in 0.5%SDS, at about 55 DEG C (low stringencies), more preferably from about 60 DEG C (middle stringency), more preferably from about 65 DEG C (medium/high stringency), even more preferably about 70 DEG C (high stringency), and even more preferably about 75 DEG C (very high stringencies) wash twice totally 30 minutes. use x-ray sheet detection under these conditions with the molecule of oligonucleotide probe hybridization.
By the disclosure is interpreted as the homogeneity degree between two sequences about polypeptide or term " homogeneity " that DNA sequence used and related to, represent the difference (derivation) between first sequence and second sequence. Homogeneity can be passed through computer program known in the art and suitably determine, GAP (ProgramManualfortheWisconsinPackage, the Version8 provided in GCG program package, August1994, GeneticsComputerGroup, 575ScienceDrive, Madison, Wisconsin, USA53711) (Needleman, and Wunsch S.B., C.D., (1970), JournalofMolecularBiology, 48,443-453). Peptide sequence is compared, uses following setting: gap opening penalty (GAPcreationpenalty) be 3.0 and gap extension penalty (GAPextensionpenalty) be 0.1. Homogeneity degree between aminoacid sequence and the different aminoacid sequences (" exogenous array ") of the present invention is calculated as below: the number mated completely in two sequence alignments, divided by the shortest person in the length of " invention sequence " or the length of " exogenous array ". Result is expressed as percentage identities.
Beerwort produces
According to first aspect, the method that the present invention is provided to produce medicated beer beerwort, wine with dregs is formed including by corn, and described wine with dregs is contacted with amylopectase (E.C.3.2.1.41), wherein said amylopectase has following aminoacid sequence, aminoacid sequence at least 50% shown in described aminoacid sequence a) and SEQIDNO:4, at least 60%, at least 70%, at least 75%, at least 80%, or at least 85%, or 90%, or at least 95%, at least 96%, at least 97%, at least 98% or even at least 99% is identical or b) by nucleic acid sequence encoding, described nucleotide sequence is at low stringency, middle stringency, medium/high stringency, high stringency, or under even very high stringent conditions with following hybridization: i) encode the complementary strand of the nucleotide sequence of aminoacid sequence shown in SEQIDNO:4, or ii) at least 100 nucleotide of (i), at least 200 nucleotide, at least 300 nucleotide, at least 500 nucleotide, at least 1000 nucleotide, or the subsequence of even at least 1500 nucleotide. in a preferred embodiment, amylopectase has aminoacid sequence, the aminoacid sequence of described aminoacid sequence and SEQIDNO:3 is more or less the same in 100 aminoacid, it is preferably no more than 80 aminoacid, it is more preferably no more than 50 aminoacid, it is more preferably no more than 30 aminoacid, even more preferably from no more than 20 aminoacid, and most preferably no more than 10 aminoacid.
The corn of first aspect includes amyloid germinated ceral and/or adjuvant. Corn can preferably include 0%-100%, it is preferable that 20%-100%, it is preferable that 30%-100%, more preferably 40%-100%, even more preferably from 50%-100%, more preferably 60%-100%, such as the adjuvant of 80%-100% or even most preferably 90%-100%, non-germinated ceral and/or non-germinating barley. In a specific embodiment, adjuvant is made up of 100% non-germinating barley. Additionally, corn preferably comprises 0%-100%, it is preferable that 20%-100%, preferred 30%-100%, more preferably 40%-100%, even more preferably from 50%-100%, more preferably 60%-100%, or most preferably 70%-100%, or even most preferably 90%-100% germinated ceral and/or non-germinating barley. In a specific embodiment, corn comprises about 50% germinated ceral, for instance, germinating barley, and about 50% adjuvant, for instance non-germinated ceral, such as non-germinating barley.
The germinated ceral used in the method for first aspect includes the corn of any germination, and is preferably selected from the germinated ceral of the Fructus Hordei Vulgaris, Semen Tritici aestivi, rye (Secale cereale L.), Sorghum vulgare Pers., broomcorn millet, Semen Maydis and the rice that germinate, and most preferably germinating barley.
The adjuvant used in the method for first aspect can obtain from tuber, root, stem, leaf, beans, frumentum and/or complete grain. Adjuvant can comprise raw and/or purified starch and/or sugary material, it is derived from plant, such as Semen Tritici aestivi, rye (Secale cereale L.), Herba bromi japonici, Semen Maydis, rice, buys sieve Sorghum vulgare Pers. (milo), broomcorn millet, Sorghum vulgare Pers., Rhizoma Solani tuber osi, Rhizoma Dioscoreae esculentae, Maninot esculenta crantz. (cassava), tapioca (tapioca), sago (sago), Fructus Musae, sugar beet and/or Caulis Sacchari sinensis. Preferably, accessory package is containing non-germinated ceral, for instance, the non-germinated ceral selected from following: Fructus Hordei Vulgaris, Semen Tritici aestivi, rye (Secale cereale L.), Sorghum vulgare Pers., broomcorn millet, Semen Maydis and rice, and most preferably non-germinating barley. Before the method for saccharifying of the present invention, in process or afterwards, it is possible to add in barley malt wine with dregs and comprise the carbohydrate that can be easy to fermentation such as the adjuvant of sugar or syrup, but add preferably in after method for saccharifying.
According to the present invention, amylopectase (E.C.3.2.1.41) enzymatic activity is provided by external source and is present in wine with dregs. Can formed before wine with dregs, in process or rear in wine with dregs composition such as water and/or corn, add amylopectase. In particularly preferred embodiments, ��-amylase (E.C.3.2.1.1) and/or glucoamylase (E.C.3.2.1.3) add together with amylopectase, and are present in wine with dregs.
In another preferred embodiment, adding other enzyme in wine with dregs, described enzyme is selected from lower group: isoamylase, protease, laccase, xylanase, lipase, phospholipase, phytase, phytin (phytin) and esterase.
In method for saccharifying, the starch extracted from corn is hydrolyzed into fermentable sugared and less dextrin gradually. Preferably, before extracting beerwort, iodine test is starch negative by wine with dregs.
The temperature of method for saccharifying is generally stepped up under control, and in wherein often walking, the effect of a kind of enzyme surpasses other enzyme, final protein degradation matter, cell wall and starch. Saccharification temperature curve is generally known in the art. In the present invention, saccharifying (starch degradation) step in method for saccharifying is preferably in 60 DEG C-66 DEG C, more preferably in 61 DEG C-65 DEG C, even more preferably in 62 DEG C-64 DEG C, and carries out most preferably at 63 DEG C-64 DEG C. In one embodiment of the invention, saccharification temperature is 64 DEG C.
Obtaining beerwort from wine with dregs and generally include the beerwort elimination (strain) distiller grains, namely described distiller grains form insoluble grain and the rice husk material of the part of corn. Hot water can be gone out the extract of any remnants by distiller grains with flushing or drip washing (sparge) from corn. Application heat-stable cellulase causes that beta glucan level effectively declines to promote wort filtration in the method for the invention, so that it is guaranteed that circulation time reduces and high extraction recovery. Preferably, extraction recovery is at least 80%, it is preferable that at least 81%, more preferably at 82%, and even more desirably at least 83%, such as at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, and most preferably at least 91%.
After the corn distiller grains separation of wort of any of above embodiment of first aspect, it is possible to be used as is beerwort or by its dehydration to provide concentration and/or dry beerwort. Concentration and/or dry beerwort can serve as wine brewing extract, and Fructus Hordei Germinatus extract flavoring agent (flavoring), for nonalcoholic Fructus Hordei Germinatus beverage, malt vinegar, breakfast cereals, for confection etc.
In a preferred embodiment, fermenting wort is to produce alcoholic beverage, preferably beer, such as, like youngster's medicated beer (ale), strong love youngster's medicated beer (strongale), Bitter (bitter), stou (stout), alms bowl that dark beer (porter) thoroughly, old storage medicated beer (lager), export-oriented medicated beer (exportbeer), malt liquor (maltliquor), barley broo, low malt medicated beer (happoushu), high alcohol beer (high-alcoholbeer), low alcohol beer (low-alcoholbeer), low-heat beer (low-caloriebeer) or light beer (lightbeer). the fermentation of beerwort can include input (pitchwith) yeast slurry in beerwort, and this slurry comprises fresh yeast (being namely previously not used for the yeast of the present invention) or described yeast can be the yeast reclaimed. the yeast of application can be adapted for any yeast of brewing, it is especially selected from the yeast of Saccharomyces sp (Saccharomycesspp.), such as saccharomyces cerevisiae and Saccharomyces uvarum (S.uvarum), it includes the natural or artificially generated variant of these organisms. it is known by those skilled in the art for producing the fermentation process of the beerwort of medicated beer.
The method of the present invention can include adding silica hydrogel (silicahydrogel) in fermenting wort, to increase the colloidal stability (colloidalstability) of medicated beer. These methods can also include adding kieselguhr (kieselguhr) in the beerwort of fermentation and filtering so that medicated beer vivid (bright).
According to an aspect of the present invention, it is provided that the medicated beer produced by the beerwort of second or third aspect, the medicated beer as produced by beerwort fermentation is produced medicated beer. Medicated beer can be any type beer, such as, youngster's medicated beer, strong love youngster's medicated beer, stou, alms bowl that dark beer, old storage medicated beer, Bitter, export-oriented medicated beer, malt liquor, low malt medicated beer, high alcohol beer, low alcohol beer, low-heat beer or light beer thoroughly are liked.
Enzyme
To be applied to the exogenous enzyme in the present invention should according to they treatment temperatures in the methods of the invention and their pH in wine with dregs when keep the ability of fully activity to select, and should add with effective dose. Enzyme can be derived from any source, it is preferable that from plant or algae, more preferably from microorganism, as from antibacterial or fungus.
Amylopectase (E.C.3.2.1.41)
The preferred amylopectase used in the method and/or compositions of the present invention is the amylose enzyme with following aminoacid sequence, described aminoacid sequence and the sequence at least 50% shown in SEQIDNO:4, such as at least 55%, such as at least 60%, such as at least 65%, such as at least 66%, such as at least 70%, such as at least 75%, such as at least 80%, such as at least 85%, such as at least 86%, such as at least 87%, such as at least 88%, such as at least 89%, such as at least 90%, such as at least 95%, as at least 98% or even 100% is identical; Particularly when using following setting with Needle program comparison: matrix is BLOSUM62, and breach initiates point penalty 10.0, gap extension penalty 0.5, non-notch homogeneity matrix.
Most preferably, amylopectase is derived from addicted to acid Pullulan bacillus cereus (Bacillusacidopullulyticus). Amylopectase can have by Kelly etc., aminoacid sequence or homologous sequence disclosed in 1994 (FEMSMicrobiol.Letters115:97-106) (SEQIDNO:6).
Isoamylase (E.C.3.2.1.68)
The another kind of enzyme used in the method for the present invention and/or compositions can be interchangeable debranching enzyme, such as isoamylase (E.C.3.2.1.68). ��-1 in Isoamylase hydrolyses amylopectin (amylopectin) and ��-limit dextrin, 6-D-glucosides branch key, and can not attack amylopectin by isoamylase and be different from amylopectase by the limited action to ��-limit dextrin. Isoamylase can add by effective dose well known to those skilled in the art. Isoamylase can be individually added into or add together with amylopectase.
��-amylase (EC3.2.1.1)
The specific ��-amylase used in the method for the present invention and/or compositions can be bacillus (Bacillus) ��-amylase. Known Bacillus alpha-amylase includes the ��-amylase being derived from the bacterial strain of Bacillus licheniformis (B.licheniformis), bacillus amyloliquefaciens (Bacillusamyloliquefaciens) and bacstearothermophilus (B.stearothermophilus). In the context of the present invention, it is desirable to Bacillus alpha-amylase be that WO99/19467 page 3 the 18th walks to ��-amylase defined in the 6th page of the 27th row. Preferred ��-amylase has aminoacid sequence, and it has at least 90% homogeneity with SEQIDNO:4 (disclosed herein for SEQIDNO:7) in WO99/19467, such as at least 92%, at least 95%, at least 96%, at least 97%, at least 98%, or particularly at least 99%. Most preferred product maltogenic alpha-amylase enzyme is SEQIDNO:9 or includes its variant disclosed in WO99/43794. Desired variant and heterozygote are described in WO96/23874, WO97/41213 and WO99/19467. The ��-amylase (E.C.3.2.1.1) originating from bacstearothermophilus being especially desired to, it has in WO99/19467 the aminoacid sequence (disclosed herein for SEQIDNO:10) disclosed in SEQIDNO:3, and it has sudden change: I181*+G182*+N193F.
Bacillus alpha-amylase can with 1.0-1000NU/kgDS, it is preferable that 2.0-500NU/kgDS, it is preferable that the amount of 10-200NU/kgDS adds.
The another kind of specific ��-amylase that the method for the present invention uses can be any fungal alpha-amylase. Such as, it is derived from the ��-amylase of aspergillus (Aspergillus) interior strain, and is preferred from the bacterial strain of aspergillus niger (Aspergillusniger). What be especially desired to is show high homogeneity with the aminoacid sequence (disclosed herein for SEQIDNO:11) shown in SEQIDNO:1 in WO2002/038787, namely at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, the fungal alpha-amylase of at least 80%, at least 85% or even at least 90% homogeneity. Fungal alpha-amylase can with 1-1000AFAU/kgDS, it is preferable that 2-500AFAU/kgDS, it is preferable that the amount of 20-100AFAU/kgDS adds.
Glucoamylase (E.C.3.2.1.3)
The another kind of specific enzyme used in the method for the present invention and/or compositions can be derived from the glucoamylase (E.C.3.2.1.3) of microorganism or plant. Preferably one or more the glucoamylase in lower group of fungus or bacterial origin: Aspergillus glucoamylase, particularly aspergillus niger G1 or G2 glucoamylase (Boel etc., 1984, EMBOJ.3 (5): 1097-1102), or their variant, as disclosed in WO92/00381 and WO00/04136; Aspergillus awamori (A.awamori) glucoamylase (WO84/02921), aspergillus oryzae (A.oryzae) (Agric.Biol.Chem., 1991,55 (4): 941-949), or its variant or fragment.
Other desired glucoamylase includes Talaromyces (Talaromyces) glucoamylase, particularly it is derived from Ai Mosen ankle joint bacterium (Talaromycesemersonii) (WO99/28448), Talaromycesleycettanus (U.S. Patent number Re.32,153), Du Pont's ankle joint bacterium (Talaromycesduponti) and thermophilic ankle joint bacterium (Talaromycesthermophilus) (U.S. Patent number 4,587,215) glucoamylase. Preferred glucoamylase includes the glucoamylase being derived from aspergillus oryzae, the aminoacid sequence as shown in the SEQIDNO:2 in WO00/04136 has at least 90%, at least 92%, at least 95%, at least 96%, the glucoamylase of at least 97%, at least 98% or particularly at least 99% or even at least 90% homogeneity. Other preferred glucoamylase includes the glucoamylase being derived from Ai Mosen ankle joint bacterium, aminoacid sequence (WO99/28448) as saved bacterium with Ai Mosen ankle has at least 90%, at least 92%, at least 95%, at least 96%, at least 97%, at least 98%, or particularly at least 99%, or the glucoamylase of even at least 90% homogeneity.
Desired antibacterial glucoamylase includes the glucoamylase from fusobacterium (Clostridium), particularly pyrolysis clostridium amylobacter (C.thermoamylolyticum) (EP135,138) and Clostridium thermohydrosulfuricum (C.thermohydrosulfuricum) (WO86/01831).
It is also contemplated that commercial product AMG200L; AMG300L; SANTMSUPER and AMGTME (from Novozymes); OPTIDEXTM300 (from GenencorInt.); AMIGASETMAnd AMIGASETMPLUS (from DSM); G-ZYMETMG900 (from EnzymeBio-Systems); G-ZYMETMG990ZR (aspergillus niger glucoamylase and low protease content). Glucoamylase can be added with effective dose well-known to those skilled in the art.
Protease
Suitable protease includes microbial protease, such as fungus and bacterialprotease. Preferred protease is acid protease, i.e. by the protease of the capability representation at the hydrolyzed under acidic conditions protein lower than pH7.
Protease is responsible in wine with dregs the high-molecular-weight protein of total length is degraded into low molecular weight protein (LMWP). Low molecular weight protein (LMWP) is required for the nutrition of yeast, and high-molecular-weight protein ensures foam stability. Therefore technical staff knows protease and should add with aequum, provides slowly (amble) free amino acid and retain enough high-molecular-weight proteins so that foam stabilising for yeast simultaneously. Can with 0.1-1000AU/kgDS, it is preferable that the amount of 1-100AU/kgDS and most preferably 5-25AU/kgDS adds protease.
Cellulase (E.C.3.2.1.4)
Cellulase can be microbe-derived, as be derived from filamentous fungi (such as, aspergillus, trichoderma (Trichoderma), Humicola (Humicola), Fusarium (Fusarium)) bacterial strain. The instantiation of cellulase includes from Humicola insolens (H.insolens) obtainable endoglucanase (endoglucanase), it is also defined by the aminoacid sequence of Figure 14 in WO91/17244, and the endoglucanase of 43kD Humicola insolens described in WO91/17243.
The special fiber element enzyme used in the method for the present invention can be endoglucanase, such as inscribe-Isosorbide-5-Nitrae-1,4 beta-glucanase. What be especially desired to is the 1,4 beta-glucanase (disclosed herein for SEQIDNO:14) shown in SEQIDNO:2 and homologous sequence in WO2003/062409. Operable commercially available cellulase preparation includesWith(can obtain from NovozymesA/S), LAMINEXTMWithCP (can obtain from GenencorInt.) and7069W (can be fromGermany obtains).
Can with 1.0-10000BGU/kgDS, it is preferable that 10-5000BGU/kgDS, it is preferable that the amount of 50-1000BGU/kgDS and most preferably 100-500BGU/kgDS adds 1,4 beta-glucanase.
Materials and methods
Enzyme:
Amylopectase 1, it is derived from addicted to acid Pullulan bacillus cereus, and has sequence shown in SEQIDNO:1. Amylopectase 1 can be obtained as Promozyme400L by Novozymes.
Amylopectase 2, it is derived from Bacillusderamificans (U.S. Patent No. 5,736,375), and has sequence shown in SEQIDNO:2. Amylopectase 2 can be obtained as PromozymeD2 by Novozymes.
Amylopectase 3, it is derived from addicted to acid Pullulan bacillus cereus, and has sequence shown in SEQIDNO:4.
Acid Fungal Alpha-amylase, it is derived from aspergillus niger, and has sequence shown in SEQIDNO:11.
Glucoamylase G1, it is derived from aspergillus niger (boel etc. see above).
Method:
Alpha-amylase activity (NU)
Potato starch is used to may determine that alpha-amylase activity as substrate. This method is based on the decomposition by enzyme of modified (modified) potato starch, and follows the tracks of this reaction by being mixed with iodine solution by the sample of starch/enzymatic solution. Originally, form black-and-blue (blackishbluecolor), but in amylolysis process, blueness is more and more shallow, and gradually become bronzing (reddish-brown), by it compared with colored glass standard.
1000 Novo ��-amylase unit (KNU) are equal to 1000NU. One KNU is defined as at the standard conditions (that is, 37 DEG C of +/-0.05; 0.0003MCa2+; And pH5.6) enzyme amount of 5.26g starch dry matter (MerckAmylumsolubile) that degrade.
Acid alpha-amylase activity (AFAU)
Acid alpha-amylase activity can measure with AFAU (Acid Fungal Alpha-amylase unit), and it is determined relative to enzyme reference material. 1FAU is defined as the enzyme amount of 5.260mg starch dry matter of degrading per hour under following standard conditions.
Acid alpha-amylase is inscribe-��-amylase (Isosorbide-5-Nitrae-��-D-glucosan-glucan hydrolase, E.C.3.2.1.1), the ��-Isosorbide-5-Nitrae-glycosidic bond in catalytic starch intramolecule region, forms dextrin and the oligosaccharide of different chain length. Iodine is directly proportional to starch concentration to the blue intensity of Starch formation. Use reverse colorimetry, measure when particular analysis the minimizing of starch concentration as amylase activity.
Standard conditions/reaction condition:
Glucoamylase activity (AGU)
Novo glucoamylase unit (AGU) is defined as the enzyme amount at 37 DEG C He pH4.3 hydrolysis 1 per minute micromole maltose.
Use from BoehringerMannheim, the GlucoseGOD-Perid test kit of 124036, determine activity by the method revised according to (AEL-SM-0131 can require to obtain from Novozymes) with AGU/ml. Standard substance: AMG-standard substance, lot number 7-1195,195AGU/ml. By 375 �� L substrates (50mM sodium acetate, 1% maltose in pH4.3) 37 DEG C of incubations 5 minutes. Add the 25 �� L enzymes being diluted in sodium acetate. After 10 minutes, by adding 100 �� L0.25MNaOH and stopped reaction. 20 �� L are transferred to 96 hole microtitration plates and add 200 �� LGOD-Perid solution (124036, BoehringerMannheim). After 30 minutes, at the absorbance at room temperature measuring 650nm place, and by AMG-standard substance, with AGU/ml calculated activity. The detailed description of analysis method (AEL-SM-0131) can require to obtain from Novozymes.
Pullulanase activity (PUN):
One Pullulanase Unit (PUN) is defined as in the citrate buffer of pH5, can from the enzyme amount of pullulan substrate formation 1 per minute micromoles glucose at 50 DEG C.
Amylopectase sample is incubation together with substrate (red amylopectin). ��-1 in inscribe amylopectin enzyme hydrolysis redness amylopectin, 6-glycosidic bond, discharge red substrate degradation product. Ethanol is used to be precipitated by undegradable substrate. Discharging the amount of color at 510nm spectrophotometry, it is proportional to the inscribe-Pullulanase activity in sample. Compared with the color that the sample that the color of sample is formed with Pullulanase activity is known produces is formed.
Amylopectase is amylopectin 6-glucosan-hydrolytic enzyme, and enzyme classification number is E.C.3.2.1.41.
Reaction condition
Reagent/substrate
Klorvess Liquid 0.5M
Red pullulan substrate 2%. Supplier is Megazyme, Australia
Citrate buffer 0.05MpH5.0
Citrate buffer 0.05MpH5.0 including 25mM cysteine
Ethanol 99.8%
The amylopectase standard substance prepared product of 904PUN/g is diluted in citrate buffer 0.05M the standard dilutions series of 0.05-0.20PUN/ml.
Blank citrate buffer 0.05M
Enzyme sample is diluted in citrate buffer 0.05M activity for 0.06-0.20PUN/ml, and with standard dilutions series of comparisons.
Embodiment 1
In this embodiment, different amylopectases is analyzed to reduce the ability of the not amount of fermentable sugars (dextrin/DP4/4+) in beerwort.
Using following saccharification temperature curve by 100% malt amylase fully modified, described saccharification temperature curve includes 46 DEG C 26 minutes, then increases to 64 DEG C with 1 DEG C/min, makes temperature remained constant afterwards. Sample is collected at 98,128 and 158 minutes.
Enzyme is added at 0 minute. In all process, glucoamylase and ��-amylase is added respectively with 1000AGU/kgDS and 250AFAU/kgDS. Amylopectase is added according to table 1.
Sample boiled 10 minutes and filter (0.20 micron of aperture). Analyze sample by HPLC, and calculate the percentage ratio of not fermentable sugars (DP4/4+).
Use the data in table 1, by returning, calculate with the 2.74mg pheron/kg same effect of amylopectase 3 needed for amylopectase 1 and the enzyme dosage (see table 2) of amylopectase 2.
By these results it can be seen that amylopectase 3 is maximally effective enzyme. Therefore, amylopectase 3 pheron of the amount needs reducing not fermentable sugars (dextrin/DP4/4+) is less, thereby increases the fermentation (attenuation) of beerwort.
Embodiment 2
Analyze pH curve and the temperature curve of different amylopectase in the present embodiment.
Carry out the research of pH and temperature curve according to alive analysis of relative enzyme by following condition.
Analyze Method And Principle:
By ��-1 in amylopectase hydrolyzing amylopectin, 6-glycosidic bond, and the reducing sugar amount increased by the Somogyi-Nelson method detection revised.
In this experiment, evaluating activity with relative activity, wherein the strongest sample of activity is appointed as 100%. Testing conditions is as follows:
Buffer: citrate 0.1M+0.2M phosphate (regulates, be pH5 in temperature curve) in pH curve
Substrate: 0.2% amylopectin Sigma (p-4516)
Temperature: be 60 DEG C in pH curve, regulates in temperature curve
Response time: 30 minutes
According to Nelson, 1944, the principle detection described in J.Biol.Chem.153:375-380 and Somogyi, 1945, J.Biol.Chem.160:61-68 is by the reducing sugar of amylopectin enzyme r e lease. In short, by add SomogyiShi copper (cobber) reagent corresponding to the volume of sample volume (such as, the sample of 2ml adds 2ml) and to terminate hydrolysis. Sample is boiled 20 minutes, and cool down before color reaction. Reacted corresponding to the Nelson reagent (such as, adding 2ml during sample+Somogyi cupferron 4ml altogether) of sample 1/2 volume by addition. Sample mix 2 minutes, is subsequently adding and the water of Nelson reagent equivalent. In the dark incubated samples 30 minutes, and measure at 540nm in spectrophotometer.
Reagent can be made by:
Somogyi cupferron
At 1000mlH2O dissolves 70.2gNa2HPO4x2H2O and 80.0gKNAC4H4O6x4H2O (kaliumsodiumtartrat (sodium potassium tartrate tetrahydrate)) (slightly heating). Add 60gNaOH; 16.0gCuSO4x5H2O and 360.0gNa2SO4And add water to 2000ml. PH to 10.8 is adjusted with NaOH
Nelson reagent:
At 1200mlH2O dissolves 100.0g (NH4)6Mo7O24x7H2O. It is carefully added into 84.0mlH2SO4. Additionally, at 100mlH2O dissolves 12.00gNa2HAsO4x7H2O (disodium hydrogen arsenate), and this solution is slowly added in the first solution and adds water to 2000ml.
Table 3 below and 4 gives pH and the temperature curve of three kinds of amylopectases.
These are it is shown that compare with other two kinds of amylopectases, and amylopectase 3 has wide pH curve and activity when high temperature. These character make amylopectase 3 become enzyme very sane in wine brewing (saccharifying condition), especially for when saccharification temperature is 62 DEG C-65 DEG C.
Embodiment 3
Carry out leaching saccharifying (infusionmashing) test with amylopectase 1 and 3 (SEQIDNO:1 and 4). 6 saccharifying samples are prepared for substrate (corn) with 100% Fructus Hordei Vulgaris.
Fructus Hordei Vulgaris (DS%:86.73) is ground, and for each sample, by the 50.0g sample (total DS43.34g) the 200g tap water with 50 DEG C and 3.0ml1MH3PO4Mixing.
All samples all adds the identical enzymatic mixture of pullulan free enzyme.
Then amylopectase is added according to following table to sample 1-6:
Enzyme dose active/g
Then test sample in the automatization's sacchariferous equipment running following program.
Time (minute) Temperature DEG C
0-30 50
30-44 Rise to 64
44-104 64
104-120 Rise to 80
120-140 80
140-155 It is down to 20
After saccharifying, all samples all adds tap water and to 300g altogether and filters. Then the sample of filtration is boiled 10 minutes and dilute with deionized water 1:1. By centrifugal for 50ml subsample column criterion density analysis of going forward side by side, calculate RDF% (true horizon of fermentation). Result provides as RDF% with the % beerwort represented sugar (DP2 and DP4+).
PUN/g Amylopectase 1 Amylopectase 3
0 0 0
0.1 64 64.6
0.2 65 66.1
0.5 67.3 69.5
It is shown that for obtaining high %RDF, amylopectase 3 is substantially better than amylopectase 1, and amylopectase 3 can produce the maltose level (DP2 level) even better than amylopectase 1.
Embodiment 4
Carrying out leaching saccharifying test with amylopectase 3 (SEQIDNO:4), the maltose to evaluate amylopectase 3 produces character. 6 saccharifying samples are prepared for substrate (corn) with 100% Fructus Hordei Vulgaris.
Fructus Hordei Vulgaris (DS%:86.73) is ground, and for each sample, by the 50.0g sample (total DS43.34g) the 200g tap water with 50 DEG C and 5%Na2SO3And 1MH3PO4Mixing.
All samples all adds the identical enzymatic mixture of pullulan free enzyme.
Then amylopectase 3 is added according to following table to sample 1-6:
Then following program test sample in automatization's sacchariferous equipment is run.
After saccharifying, in all samples, add tap water to total amount be 300g and filter. Then filtered sample is boiled 10 minutes, and dilute with deionized water 1:1. 50ml subsample is centrifuged and is analyzed. Result is as follows:
PUN/g % glucose % maltose % dextrin RDF%
0 3.8 47.5 34 61.2
0.1 3.8 48.2 32 63.2
0.3 3.8 49.8 28.8 65.7
0.5 3.7 51.2 26.4 68.6
1 3.7 52.6 23.9 71
2 3.6 55.6 20.1 74.3
Result shows that maltose concentration increases along with the dosage of amylopectase 3 and increases, and the after fermentation of the increase of maltose % (RDF%) increases. Dextrin part (HPLC analyzes DP4/4+) reduces at the same time.
Only barley beta-amylase can produce maltose in this reaction, and amylopectase 3 can promote the effect of beta amylase of Fructus Hordei Vulgaris.
Concentration of glucose is low, and not by the impact of amylopectase 3 effect, advantage when this is to ferment the beerwort produced. By barley beta-amylase, and being increased by the fermentation (RDF%) of beerwort, amylopectase 3 helps degraded dextrin, and promotes the formation of maltose.

Claims (17)

1. the method being used for producing medicated beer beerwort (Brewer ' swort), forms wine with dregs including from corn, contacts with amylopectase with by described wine with dregs, and wherein said amylopectase has following aminoacid sequence:
A) identical with aminoacid sequence at least 86% shown in SEQIDNO:4; Or
B) by nucleic acid sequence encoding, described nucleotide sequence under low stringent condition with following hybridization:
I) complementary strand of the nucleotide sequence of aminoacid sequence shown in coding SEQIDNO:4; Or
Ii) subsequence of at least 100 nucleotide of (i).
2. method according to claim 1, wherein said amylopectase is derived from addicted to acid Pullulan bacillus cereus (Bacillusacidopullulyticus).
3. the method according to claim 1 or 2, it farther includes to contact described wine with dregs with glucoamylase and/or ��-amylase.
4. the method any one of aforementioned claim, wherein glucoamylase and/or ��-amylase are derived from aspergillus niger (Aspergillusniger) or Ai Mosen ankle joint bacterium (Talaromycesemersonii).
5. the method any one of aforementioned claim, it farther includes to contact described wine with dregs with the enzyme selected from lower group: cellulase, isoamylase, xylanase and protease.
6. the method any one of aforementioned claim, wherein said corn includes the grain germinateing and/or not germinateing.
7. the method any one of aforementioned claim, the grain wherein not germinateed and/or the grain of germination are selected from following: Fructus Hordei Vulgaris, Semen Tritici aestivi, rye (Secale cereale L.), Sorghum vulgare Pers., broomcorn millet, Semen Maydis and rice.
8. the method any one of aforementioned claim, the grain wherein germinateed includes the germination grain being selected from the Fructus Hordei Vulgaris, Semen Tritici aestivi, rye (Secale cereale L.), Sorghum vulgare Pers., broomcorn millet, Semen Maydis and the rice that germinate.
9. the method any one of aforementioned claim, wherein said beerwort is concentration and/or dries.
10. the method any one of aforementioned claim, it also includes fermenting wort to obtain alcoholic beverage.
11. method according to claim 10, wherein said alcoholic beverage is medicated beer.
12. method according to claim 11, wherein said medicated beer is to like youngster's medicated beer, strong love youngster's medicated beer, Bitter, stou, alms bowl that dark beer, old storage medicated beer, export-oriented medicated beer, malt liquor, barley broo, low malt medicated beer, high alcohol beer, low alcohol beer, low-heat beer or light beer thoroughly.
13. the beerwort produced by the method any one of aforementioned claim.
14. the concentration any one of aforementioned claim and/or dry beerwort.
15. the medicated beer produced by the beerwort any one of aforementioned claim.
16. the compositions suitable in the method any one of aforementioned claim, described compositions includes amylopectase, glucoamylase and optional ��-amylase, and wherein said amylopectase has following aminoacid sequence, described aminoacid sequence
A) identical with aminoacid sequence at least 50% shown in SEQIDNO:4; Or
B) by under low stringent condition with the nucleic acid sequence encoding of following hybridization:
I) coding SEQIDNO:4 shown in aminoacid sequence nucleotide sequence complementary strand or
Ii) subsequence of at least 100 nucleotide of (i).
17. compositions according to claim 16, wherein glucoamylase and/or ��-amylase are derived from aspergillus niger or Ai Mosen ankle joint bacterium.
CN201610097716.7A 2007-12-12 2007-12-12 Saccharifying method Pending CN105623937A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007801019200A CN101918525A (en) 2007-12-12 2007-12-12 Saccharification method

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN2007801019200A Division CN101918525A (en) 2007-12-12 2007-12-12 Saccharification method

Publications (1)

Publication Number Publication Date
CN105623937A true CN105623937A (en) 2016-06-01

Family

ID=56044447

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610097716.7A Pending CN105623937A (en) 2007-12-12 2007-12-12 Saccharifying method

Country Status (1)

Country Link
CN (1) CN105623937A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113999740A (en) * 2021-11-19 2022-02-01 广州南沙珠江啤酒有限公司 Strong beer and preparation method thereof
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1090325A (en) * 1992-12-28 1994-08-03 索尔维公司 Pullulanase, microorganism producing it, its preparation method and use
CN1309701A (en) * 1998-07-02 2001-08-22 诺沃奇梅兹有限公司 Starch debranching enzymes
CN1671833A (en) * 2002-07-25 2005-09-21 诺维信公司 Mashing process
WO2005121305A1 (en) * 2004-06-08 2005-12-22 Novozymes A/S Mashing process

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1090325A (en) * 1992-12-28 1994-08-03 索尔维公司 Pullulanase, microorganism producing it, its preparation method and use
CN1309701A (en) * 1998-07-02 2001-08-22 诺沃奇梅兹有限公司 Starch debranching enzymes
CN1671833A (en) * 2002-07-25 2005-09-21 诺维信公司 Mashing process
WO2005121305A1 (en) * 2004-06-08 2005-12-22 Novozymes A/S Mashing process

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
杨兵: "运用不同质量的麦芽进行双醪浸出糖化工艺的研究", 《食品与发酵工业》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113999740A (en) * 2021-11-19 2022-02-01 广州南沙珠江啤酒有限公司 Strong beer and preparation method thereof
CN113999740B (en) * 2021-11-19 2023-12-01 广州南沙珠江啤酒有限公司 Strong beer and preparation method thereof
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Similar Documents

Publication Publication Date Title
EP2222830B1 (en) Mashing process
CN102277341B (en) Alcohol product processes
CN101952409B (en) Brewing process
CN102220191B (en) Saccharification process
RU2426775C2 (en) Wort production method
CN103502420B (en) Method for producing beer wort
EP2499227B1 (en) A brewing method
US20060057684A1 (en) Mashing process
WO2007144393A1 (en) Mashing process
CN104718289A (en) Method for producing beer wort
WO2005121305A1 (en) Mashing process
CN102186965B (en) Brewing process
CN109923201A (en) The method for preparing grain extract
EP2222831B1 (en) Brewing process
US8765199B2 (en) Mashing process
CN105623937A (en) Saccharifying method
JP2025063767A (en) Wort production method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160601